Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation

View through CrossRef
Abstract Background/Aims: NLRC3 inhibits inflammatory responses. Epidemiological studies indicate that neuroinflammation induces and accelerates the onset of Alzheimer's disease (AD). This study was designed to determine whether NLRC3 plays a role in neuroinflammation, Aβ accumulation and neuroprotection in AD mice. Methods: Thirty 12-month-old APP/PS1 transgenic mice were randomized into three groups as model group, APP/PS1 +LVCON307 and APP/PS1 +LV-NLRC3 group. Ten 12-month-old wild-type C57 mice were chosen as control group. Mice in APP/PS1 +LVCON307 and APP/PS1 +LV-NLRC3 group were injected with LVCON307 or LV-NLRC3 through intracerebroventricular injection. Six months after LVCON307 or LV-NLRC3 injection, We carried out Morris water maze test on mice and harvested their brain tissues after the behavioral experiment. The deposition of amyloid protein and the changes of Nissle bodies were observed by ThS and Nissle staining. The expressions of NLRC3, 6E10, GFAP, Iba1, NeuN and PI3K were detected by immunohistochemistry or immunofluorescence. Western blot was used to analyze the expression of NLRC3, PI3K, GFAP and Iba1. Results: The expression of NLRC3 is down-regulated in brain tissues of APP/PS1 mice. Mice in APP/PS1 group had a significant attenuation of learning and memory ability compared to the control group, the ability of learning and memory was improved in APP/PS1 +LV-NLRC3 mice. The expression of 6E10, GFAP, Iba1 and PI3K in brain and hippocampus slice of APP/PS1 and APP/PS1 + LVCON307 mice were significantly higher than those of the control group, while the expression of NLRC3 and NeuN was significantly lower than that of the control group. After overexpression of NLRC3, the expression of 6e10, GFAP, Iba1 and PI3K in APP/PS1 + LV-NLRC3 group was significantly lower than that in APP/PS1 and APP/PS1 + LVCON307 group, while the expression of NLRC3 and NeuN was significantly higher than that in APP/PS1 and APP/PS1 + LVCON307 group. NLRC3 co-localized with NeuN. PI3K activation with 740YP increased the expression of GFAP and Iba-1 in hippocampus with exogenous NLRC3 protein. Conclusion: NLRC3 may play an important role in the development and progression of AD. Down-regulation of NLRC3 can lead to the activation of PI3K, resulting in abnormal plaque deposition, glial cell activation and neuron loss during AD. NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation. Keywords: NLRC3 • inflammation • Aβ • neuron •PI3K •Alzheimer's disease
Title: NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation
Description:
Abstract Background/Aims: NLRC3 inhibits inflammatory responses.
Epidemiological studies indicate that neuroinflammation induces and accelerates the onset of Alzheimer's disease (AD).
This study was designed to determine whether NLRC3 plays a role in neuroinflammation, Aβ accumulation and neuroprotection in AD mice.
Methods: Thirty 12-month-old APP/PS1 transgenic mice were randomized into three groups as model group, APP/PS1 +LVCON307 and APP/PS1 +LV-NLRC3 group.
Ten 12-month-old wild-type C57 mice were chosen as control group.
Mice in APP/PS1 +LVCON307 and APP/PS1 +LV-NLRC3 group were injected with LVCON307 or LV-NLRC3 through intracerebroventricular injection.
Six months after LVCON307 or LV-NLRC3 injection, We carried out Morris water maze test on mice and harvested their brain tissues after the behavioral experiment.
The deposition of amyloid protein and the changes of Nissle bodies were observed by ThS and Nissle staining.
The expressions of NLRC3, 6E10, GFAP, Iba1, NeuN and PI3K were detected by immunohistochemistry or immunofluorescence.
Western blot was used to analyze the expression of NLRC3, PI3K, GFAP and Iba1.
Results: The expression of NLRC3 is down-regulated in brain tissues of APP/PS1 mice.
Mice in APP/PS1 group had a significant attenuation of learning and memory ability compared to the control group, the ability of learning and memory was improved in APP/PS1 +LV-NLRC3 mice.
The expression of 6E10, GFAP, Iba1 and PI3K in brain and hippocampus slice of APP/PS1 and APP/PS1 + LVCON307 mice were significantly higher than those of the control group, while the expression of NLRC3 and NeuN was significantly lower than that of the control group.
After overexpression of NLRC3, the expression of 6e10, GFAP, Iba1 and PI3K in APP/PS1 + LV-NLRC3 group was significantly lower than that in APP/PS1 and APP/PS1 + LVCON307 group, while the expression of NLRC3 and NeuN was significantly higher than that in APP/PS1 and APP/PS1 + LVCON307 group.
NLRC3 co-localized with NeuN.
PI3K activation with 740YP increased the expression of GFAP and Iba-1 in hippocampus with exogenous NLRC3 protein.
Conclusion: NLRC3 may play an important role in the development and progression of AD.
Down-regulation of NLRC3 can lead to the activation of PI3K, resulting in abnormal plaque deposition, glial cell activation and neuron loss during AD.
NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation.
Keywords: NLRC3 • inflammation • Aβ • neuron •PI3K •Alzheimer's disease.

Related Results

Nlrc3 signaling is indispensable for hematopoietic stem cell emergence via Notch signaling in vertebrates
Nlrc3 signaling is indispensable for hematopoietic stem cell emergence via Notch signaling in vertebrates
Abstract Hematopoietic stem and progenitor cells (HSPCs) generate all of the lineages of blood cells throughout the lifespan of vertebrates. The emergence of HSPCs occurs t...
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
Presenilin-1 Regulates Neural Progenitor Cell Differentiation in the Adult Brain
Presenilin-1 Regulates Neural Progenitor Cell Differentiation in the Adult Brain
Presenilin-1 (PS1) is the catalytic core of the aspartyl protease γ-secretase. Previous genetic studies using germ-line deletion ofPS1and conditional knock-out mice demonstrated th...
Abstract 301: Galectin-1 modulates PI3 kinase activity
Abstract 301: Galectin-1 modulates PI3 kinase activity
Abstract The purpose of these experiments was to study the role that Galectin-1 (GAL1) has in Phosphoinositide 3-kinase (PI3K) signaling. GAL1 protein levels have be...
Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites
Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites
Abstract The recently discovered interaction between Presenilin 1 (PS1), a catalytic subunit of γ-secretase responsible for generating amyloid-β (Aβ) peptides, and ...
Abstract 1787: Selective activation of a PI3K catalytic isoform by G protein-coupled receptors in glioblastoma
Abstract 1787: Selective activation of a PI3K catalytic isoform by G protein-coupled receptors in glioblastoma
Abstract Objective: To determine how PI3K catalytic isoforms become dysregulated in glioblastoma. Background: Recurrence in glioblastoma (GBM) i...
FAM19A5 Deficiency Mitigates the Aβ Plaque Burden and Improves Cognition in Mouse Models of Alzheimer’s Disease
FAM19A5 Deficiency Mitigates the Aβ Plaque Burden and Improves Cognition in Mouse Models of Alzheimer’s Disease
ABSTRACTFAM19A5, a novel secretory protein highly expressed in the brain, is potentially associated with the progression of Alzheimer’s disease (AD). However, its role in the AD br...

Back to Top